123 related articles for article (PubMed ID: 7577634)
1. Use of central venous catheters in children with severe congenital coagulopathy.
Liesner RJ; Vora AJ; Hann IM; Lilleymann JS
Br J Haematol; 1995 Sep; 91(1):203-7. PubMed ID: 7577634
[TBL] [Abstract][Full Text] [Related]
2. Implantable venous access devices in children with severe hemophilia: a tertiary pediatric institutional experience.
Bedoya MA; Raffini L; Durand R; Acord MR; Srinivasan A; Krishnamurthy G; Vatsky S; Escobar F; Cahill AM
Pediatr Radiol; 2020 Jul; 50(8):1148-1155. PubMed ID: 32390060
[TBL] [Abstract][Full Text] [Related]
3. Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome.
McMahon C; Smith J; Khair K; Liesner R; Hann IM; Smith OP
Br J Haematol; 2000 Aug; 110(2):461-8. PubMed ID: 10971409
[TBL] [Abstract][Full Text] [Related]
4. Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia.
Ljung R; Petrini P; Lindgren AK; Berntorp E
Acta Paediatr; 1992 Nov; 81(11):918-20. PubMed ID: 1467614
[TBL] [Abstract][Full Text] [Related]
5. Port-A-Cath usage in children with haemophilia: experience of 53 cases.
Ljung R; van den Berg M; Petrini P; Tengborn L; Scheibel E; Kekomäki R; Effenberger W
Acta Paediatr; 1998 Oct; 87(10):1051-4. PubMed ID: 9825971
[TBL] [Abstract][Full Text] [Related]
6. Complications of central venous access devices in paediatric haemophilia patients.
Domm JA; Hudson MG; Janco RL
Haemophilia; 2003 Jan; 9(1):50-6. PubMed ID: 12558778
[TBL] [Abstract][Full Text] [Related]
7. Implantable venous access devices in children with hemophilia: a report of low infection rates.
Miller K; Buchanan GR; Zappa S; Cochran C; Laufenberg J; Medeiros D; Sanders J
J Pediatr; 1998 Jun; 132(6):934-8. PubMed ID: 9627581
[TBL] [Abstract][Full Text] [Related]
8. Incidence and outcome of retained Port-A-Cath fragments during removal.
Aworanti OM; Linnane N; Tareen F; Mortell A
Pediatr Surg Int; 2017 Jul; 33(7):777-781. PubMed ID: 28584903
[TBL] [Abstract][Full Text] [Related]
9. Complications experienced with central venous catheters in children with congenital bleeding disorders.
Collins PW; Khair KS; Liesner R; Hann IM
Br J Haematol; 1997 Oct; 99(1):206-8. PubMed ID: 9359525
[TBL] [Abstract][Full Text] [Related]
10. A prospective clinical trial of implantable central venous access in children with haemophilia.
Santagostino E; Gringeri A; Muça-Perja M; Mannucci PM
Br J Haematol; 1998 Sep; 102(5):1224-8. PubMed ID: 9753049
[TBL] [Abstract][Full Text] [Related]
11. The use of central venous catheters (portacaths) in children with haemophilia.
Bollard CM; Teague LR; Berry EW; Ockelford PA
Haemophilia; 2000 Mar; 6(2):66-70. PubMed ID: 10781190
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters.
Mancuso ME; Mannucci PM; Sartori A; Agliardi A; Santagostino E
Br J Haematol; 2008 May; 141(5):689-95. PubMed ID: 18410458
[TBL] [Abstract][Full Text] [Related]
13. The use of the Port-A-Cath in children with haemophilia--a review.
Van Den Berg HM; Fischer K; Roosendaal G; Mauser-Bunschoten EP
Haemophilia; 1998 Jul; 4(4):418-20. PubMed ID: 9873764
[TBL] [Abstract][Full Text] [Related]
14. Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
Titapiwatanakun R; Moir C; Pruthi RK; Stavlo PL; Schmidt KA; Rodriguez V
Haemophilia; 2009 Jan; 15(1):168-74. PubMed ID: 19149849
[TBL] [Abstract][Full Text] [Related]
15. Complications of central venous catheters in patients with haemophilia and inhibitors.
Morado M; Jimenez-Yuste V; Villar A; Quintana M; Del Castillo F; Garzon G; Acitores I; Ibañez F; Sanjurjo MJ; Gago J; Hernandez-Navarro F
Haemophilia; 2001 Nov; 7(6):551-6. PubMed ID: 11851752
[TBL] [Abstract][Full Text] [Related]
16. The risk associated with indwelling catheters in children with haemophilia.
Ljung R
Br J Haematol; 2007 Sep; 138(5):580-6. PubMed ID: 17686052
[TBL] [Abstract][Full Text] [Related]
17. Experiences with the use of the Port-a-Cath in children.
Soucy P
J Pediatr Surg; 1987 Aug; 22(8):767-9. PubMed ID: 3656030
[TBL] [Abstract][Full Text] [Related]
18. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
19. Central venous catheter with subcutaneous injection port (Port-A-Cath): 8 years clinical follow up with children.
Wesenberg F; Flaatten H; Janssen CW
Pediatr Hematol Oncol; 1993; 10(3):233-9. PubMed ID: 8217538
[TBL] [Abstract][Full Text] [Related]
20. rVIIa therapy to secure haemostasis during central line insertion in children with high-responding FVIII inhibitors.
Smith OP; Hann IM
Br J Haematol; 1996 Mar; 92(4):1002-4. PubMed ID: 8616058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
